Wolverine Trading’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-49,400	Closed	-$84K	–	5641
2022 Q2	$84K	Buy	49,400 +35,400	+253%	+$52.2K	﹤0.01%	3895
2022 Q1	$23K	Buy	14,000 +1,000	+8%	+$1.96K	﹤0.01%	5230
2021 Q4	$37K	Sell	13,000 -27,300	-68%	-$101K	﹤0.01%	5412
2021 Q3	$182K	Sell	40,300 -27,800	-41%	-$134K	﹤0.01%	5417
2021 Q2	$398K	Sell	68,100 -6,200	-8%	-$36.3K	﹤0.01%	4033
2021 Q1	$504K	Buy	74,300 +7,300	+11%	+$48.9K	﹤0.01%	3687
2020 Q4	$330K	Buy	67,000 +23,700	+55%	+$120K	﹤0.01%	3651
2020 Q3	$257K	Sell	43,300 -16,000	-27%	-$95.7K	﹤0.01%	3584
2020 Q2	$417K	Buy	+59,300	New	+$449K	﹤0.01%	2942
2019 Q4	–	Sell	-31,900	Closed	-$128K	–	5406
2019 Q3	$128K	Buy	31,900 +7,400	+30%	+$59.9K	﹤0.01%	3774
2019 Q2	$364K	Sell	24,500 -14,500	-37%	-$262K	﹤0.01%	3061
2019 Q1	$968K	Sell	39,000 -8,100	-17%	-$203K	﹤0.01%	2102
2018 Q4	$846K	Buy	47,100 +18,200	+63%	+$372K	﹤0.01%	2121
2018 Q3	$849K	Sell	28,900 -10,500	-27%	-$407K	﹤0.01%	2539
2018 Q2	$2.08M	Hold	39,400	–	–	0.01%	1555
2018 Q1	$2.08M	Sell	39,400 -58,300	-60%	-$3.4M	0.01%	1555
2017 Q4	$6.64M	Sell	97,700 -17,300	-15%	-$1.21M	0.02%	698
2017 Q3	$9.48M	Sell	115,000 -34,000	-23%	-$2.7M	0.04%	445
2017 Q2	$13.7M	Buy	149,000 +47,200	+46%	+$2.89M	0.06%	287
2017 Q1	$6.39M	Buy	+101,800	New	+$6.19M	0.04%	537
2016 Q4	–	Sell	-30,100	Closed	-$1.04M	–	5375
2016 Q3	$1.04M	Sell	30,100 -6,000	-17%	-$129K	﹤0.01%	1816
2016 Q2	$544K	Buy	+36,100	New	+$528K	﹤0.01%	2152